Optimal dosage and method of administration of adenosine for measuring the coronary flow reserve and the fractional flow reserve in Koreans

Korean Circulation Journal

Volumn 36, Issue 4, 2006, Pages 300-307

  Suh, Jung Won ^a,b   Koo, Bon Kwon ^a,b   Jo, Sang Ho ^a,b   Kang, Hyun Jae ^a,b   Cho, Young Seok ^a,c   Youn, Tae Jin ^a,c   Chung, Woo Young ^a,c   Chae, In Ho ^a,c   Choi, Dong Ju ^a,c   Kim, Hyo Soo ^a,b   Oh, Byung Hee ^a,b   Park, Young Bae ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Adenosine; Coronary flow reserve

Indexed keywords

ADENOSINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY LESION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HYPEREMIA; KOREA; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OPTIMAL DRUG DOSE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RIGHT CORONARY ARTERY;

EID: 33646482466     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2006.36.4.300     Document Type: Article

References (23)

1. Kern MJ. Coronary physiology revisited: practical insights from the cardiac catheterization laboratory. Circulation 2000;101:1344-51.
2. Pijls NH, van Gelder B, van der Voort P, et al. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995; 92:3183-93.
3. Lapez-Palop R, Saura D, Pinar E, et al. Adequate intracoronary adenosine doses to achieve maximum hyperaemia in coronary functional studies by pressure derived fractional reserve: a dose response study. Heart 2004;90:95-6.
4. de Bruyne B, Pijls NH, Barbato E, et al. Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 2003;107:1877-83.
5. Kim W, Takh SJ, Kim HS, et al. Assessment of coronary flow reserve with adenosine triphosphate compared to the response to adenosine. Korean Circ J 1998;28:863-70.
6. Jung HO, Seung KB, Kim BJ, et al. Comparison between nicorandil and adenosine in the measurement of coronary flow reserve using a Doppler guide wire. Korean Circ J 2002;32:391-7.
7. Park SM, Shim WJ, Shin JH, et al. Coronary blood flow velocity and coronary flow reserve in normal left anterior descending coronary arteries. J Korean Soc Echocardiogr 2000;8:146-51.
8. Yoon MH, Tahk SJ, Choi SY, et al. Effect of distal protection device on the microvascular integrity during primary stenting in acute myocardial infarction: distal protection device in acute myocardial infarction. Korean Circ J 2005;35:106-14.
9. Park KS, Kwan J, Seo JK, Hong ES, Cho SW, Lee WH. Clinical comparison of coronary flow reserve and fractional flow reserve after PTCA in patients with coronary artery disease. Korean J Med 1999;56:33-40.
10. Lee HS. Change of coronary flow reserve in the dogs: influence of atrial and ventricular pacing, ventricular preload and afterload. Korean Circ J 1999;29:251-8.
11. Seo JK, Kwan J, Kim DH, et al. Comparison of coronary flow reserve according to the degree of hypokinesia in dilated cardiomyopathy with regional asynergy. Korean Circ J 2000;30:1238-44.
12. Bax M, de Winster RJ, Schotborgh CE, et al. Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction. J Am Coll Cardiol 2004;3:534-41.
13. Wakatsuki T, Nakamura M, Tsunoda T, et al. Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction. J Am Coll Cardiol 2000;35:1835-41.
14. Garot P, Pascal O, Simon M, et al. Impact of microvascular integrity and local viability on left ventricular remodelling after reperfused acute myocardial infarction. Heart 2003;89:393-7.
15. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595-606.
16. Jeremias A, Filardo SD, Whitbourn RJ, et al. Effects of intravenous and intracoronary adenosine 5′-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation 2000;101:318-23.
17. di Segni E, Higano ST, Rihal CS, Holmes DR Jr, Lennon R, Lerman A. Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Catheter Cardiovasc Interv 2001;54:34-40.
18. Pijls NHJ, de Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med 1996;334:1703-8.
19. Pijls NHJ, Klauss V, Siebert U, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up. Circulation 2002;105:2950-4.
20. Berger A, Botman KJ, MacCarthy PA, et al. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 2005;46:438-42.
21. Kobori Y, Tanaka N, Takazawa K, Yamashina A. Usefulness of fractional flow reserve in determining the indication of target lesion revascularization. Catheter Cardiovasc Interv 2005;65: 355-60.
22. Koo BK, Kang HJ, Youn TJ, et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol 2005;46:633-7.
23. Casella G, Leibig M, Schiele TM, et al. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 2004;148:590-5.